436 related articles for article (PubMed ID: 15343378)
1. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
5. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
8. C1q and systemic lupus erythematosus.
Walport MJ; Davies KA; Botto M
Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
[TBL] [Abstract][Full Text] [Related]
9. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
10. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
11. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
12. Relevance of anti-C1q autoantibodies to lupus nephritis.
Tsirogianni A; Pipi E; Soufleros K
Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
Flierman R; Daha MR
Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
[TBL] [Abstract][Full Text] [Related]
14. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
[TBL] [Abstract][Full Text] [Related]
16. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.
O'Flynn J; Flierman R; van der Pol P; Rops A; Satchell SC; Mathieson PW; van Kooten C; van der Vlag J; Berden JH; Daha MR
Mol Immunol; 2011 Oct; 49(1-2):75-83. PubMed ID: 21855148
[TBL] [Abstract][Full Text] [Related]
17. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
18. Are anti-C1q antibodies different from other SLE autoantibodies?
Pickering MC; Botto M
Nat Rev Rheumatol; 2010 Aug; 6(8):490-3. PubMed ID: 20421881
[TBL] [Abstract][Full Text] [Related]
19. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
